Everyday AI Podcast – An AI and ChatGPT Podcast EP 287: Harnessing AI Technologies for Next-Generation Clinical Trials
Jun 5, 2024
Saurabh Jain, Executive Chairman at TrialKey.ai, brings his expertise in software engineering to discuss the future of clinical trials. He highlights how AI can revolutionize drug development by transforming unstructured data, optimizing trial designs, and improving predictions of success. Jain also addresses the ethical concerns around AI in medicine, the challenges of commercialization, and the potential for simulated trials to prioritize patient safety. The conversation reveals a transformative path ahead for the pharmaceutical industry through AI advancements.
AI Snips
Chapters
Transcript
Episode notes
Clinical Trials: A Necessary Process
- Clinical trials are essential for evidence-based medicine, verifying drug efficacy and safety.
- The rigorous process, involving animal and human trials, takes about a decade.
COVID-19: A Catalyst for Faster Trials
- COVID-19 trials demonstrated accelerated drug development, achieving results in a fraction of the usual time.
- This rapid progress, driven by global collaboration and resources, highlights potential for faster drug development.
ChatGPT: Transforming Unstructured Data
- ChatGPT's ability to process unstructured data revolutionizes clinical trial analysis.
- It converts complex trial information into structured data, enabling better decision-making.